Medicare
AHA comments on the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act.
AHA urged the Medicare Payment Advisory Commission to reconsider its pursuit of site-neutral payment policies for inpatient rehabilitation facilities and skilled-nursing facilities.
AHA shares the hospital field’s comments on legislative proposals for consideration before the Energy and Commerce Committee Health Subcommittee on Oct. 19.
AHA on Oct. 19 submitted a statement to the House Energy and Commerce Health Subcommittee on legislative proposals involving Medicare.
The Medicare Part A deductible for inpatient hospital services will be $1,632 in calendar year 2024. The annual deductible for Medicare Part B will be $240 in 2024.
AHA Urges CMS to Rigorously Enforce New Policies to Safeguard MA Coverage
The companies that make the first 10 Medicare Part D drugs selected to participate in the Medicare Drug Price Negotiation Program have agreed to participate in the program’s price negotiations, the Centers for Medicare & Medicaid Services announced.
As millions of people are losing their Medicaid coverage as a result of the redetermination process, hospitals and health systems are seeing substantial increases in uncompensated care and facing new Medicare cuts that will exacerbate their financial challenges, according to a AHA blog post …
This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs between $1 and $618 per average dose, the Centers for Medicare & Medicaid Services announced recently.
The Department of Health and Human Services announced the first list of Medicare Part D drugs subject to price negotiations, a tenet of the Inflation Reduction Act designed to reduce health care costs.